Skip to main content
. 2008 Feb 4;23(6):826–836. doi: 10.1359/JBMR.080205

FIG. 1.

FIG. 1

Dose and duration of treatment with pamidronate and zoledronic acid in patients with and without ONJ. Duration and total dose of pamidronate and zoledronic acid treatments were compared between patient groups using a Wilcoxon rank-sum test. The comparison was made between patients with ONJ and non-ONJ patients. (A) Total dose of pamidronate. (B) Total dose of zoledronic acid. Patients with ONJ received significantly higher doses of pamidronate and zoledronic acid than patients without ONJ (p < 0.0001). (C) Duration of treatment with pamidronate. (D) Duration of treatment with zoledronic acid. Patients with ONJ had a longer duration of treatment (p < 0.0001).